1,267 posters, 47 videos, 13 topics, 4 sessions, 853 authors
ePostersLive by SciGen Technologies S.A. All rights reserved.
SOHO 2026 Annual Meeting
September 9 - 12, 2026 | George R. Brown Convention Center, Houston, Texas
MPN - 555
Trial in Progress: A Phase 3, Randomized, Double-Blind, Active-Control Study of Pelabresib (DAK539) Plus Ruxolitinib vs Placebo Plus Ruxolitinib in JAK Inhibitor-Naive Adult Patients With Myelofibrosis (MANIFEST-3)
Poster Presenter
Authors
Part of Topic
Myeloproliferative Neoplasms (MPN)
KEYWORDS: myelofibrosis, myeloproliferative neoplasm, pelabresib, ruxolitinib, MANIFEST-3